PATENT CLAIM ANALYSIS

Application Number: 15933804
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["540", "593000"]

Abstract:
The present invention provides a method for producing a 4,4,7-trifluoro-1,2,3,4-tetrahydro-5H-1-benzazepine compound which has an superior agonistic activity to an arginine vasopressin V2 receptor and is useful as an active ingredient for a pharmaceutical composition for preventing and/or treating urinary frequency, urinary incontinence, enuresis, central diabetes insipidus, nocturia, nocturnal enuresis, or the like; and useful intermediates for use in the methods. The production method of the present invention is suitable for the industrial production of a medicament, because of a smaller number of steps, a higher yield, and a lower cost, as compared with the methods in the related art.

Claim (Index 10):
The method of  claim 9 , further comprising\n producing a compound of formula (6) from a compound of formula (8) and a compound of formula (7); producing a compound of formula (5) from the compound of formula (6);

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.64706
- Patent Class: 540.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14406568', '15434678', '10554150', '11598732', '10584933']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.628233464918836
- 35 USC 102 Novelty (BERT): 0.5329756429501438
- Combined Prediction Score: 0.6187076827219669
- Mean Citation Score: 236.9313
- Max Citation Score: 306.3594
- Similarity Product: 181.67473816083668

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test